Stock marketplace news live updates: Dow starts May on a green note, sheds 600+ points as coronavirus fears resurface

0
13

Stocks were reduce Friday after a latest collection of corporate benefit formula and mercantile information suggested some-more repairs from a coronavirus pandemic. News late in a event that a U.S. Food and Drug Administration had postulated Gilead’s antiviral diagnosis remdesivir puncture use authorisation to provide patients with COVID-19 did small to pierce a needle on equities.

Earlier, benefit formula from some of a many heavily weighted companies in a vital U.S. batch indices came in mixed. Amazon (AMZN) posted first-quarter sales that jumped 26% over final year, though warned that $4 billion in approaching coronavirus-related costs could drag handling income disastrous to a balance of $1.5 billion.

Meanwhile, Apple (AAPL) reported quarterly income expansion that slowed dramatically over final year, and declined to offer an opinion for a initial time in years due to doubt over a pandemic. The tech-heavy Nasdaq finished Friday’s event reduce by 3.2%

Oil giants Exxon Mobil and Chevron any posted weaker formula compared to final year as a mercantile extinction from a coronavirus and new thrust in wanton oil prices weighed on a companies. Exxon Mobil posted a initial quarterly detriment in decades, and Chevron cut a collateral outlay skeleton for a year by another $2 billion.

Click here for finish coverage of Warren Buffett and Berkshire Hathaway.Click here for finish coverage of Warren Buffett and Berkshire Hathaway.

A day earlier, a SP 500 sealed out Apr with a best monthly benefit given 1987. The blue-chip index climbed a sum of 12.68% for a month, though was still off 14% from a record high on Feb 19, and down scarcely 10% year to date.

“We foresee serve gains in many unsure resources between now and a finish of successive year. This reflects a expectancy of a miscarry in mercantile activity starting in a second half of 2020, alongside a delay of large financial and mercantile process support,” John Higgins, arch markets economist for Capital Economics, wrote in a note Thursday.

“Admittedly, unsure resources have already recovered utterly a lot of a belligerent that they mislaid after a conflict of coronavirus. And dual pivotal downside risks remain,” he added.

“First, success in containing a pathogen could be topsy-turvy as economies reopen. Second, a accord for process support competence mangle down,” he said. “But presumption these risks do not materialize, we expect that a convene will continue.”

Still, equities are entering what has historically been a worse six-month duration in terms of allied returns.

During that time frame, a SP 500 have averaged gain of only 1.5% during a May by Oct duration given 1950, according to LPL Research data, and finished a duration aloft only 64.3% of a time. In some-more new history, however, bonds constructed certain gains in 7 of a past 8 six-month durations between May and October, and as most as 10% during a identical duration in 2013.

The new batch convene comes notwithstanding ascent justification of a repairs a coronavirus pestilence and amicable enmity measures have inflicted on a domestic economy. A supervision news Thursday showed another 3.8 million Americans filed for new stagnation claims final week, bringing a sum over a past 6 weeks to some-more than 30 million.

4:06 p.m. ET: Stocks finish neatly reduce to flog off May

Here’s where a 3 vital indices settled, as of 4:06 p.m. ET:

  • SP 500 (^GSPC): -81.72 points (-2.81%) to 2,830.71

  • Dow (^DJI): -622.03 points (-2.55%) to 23,723.69

  • Nasdaq (^IXIC): -284.6 points (-3.2%) to 8,604.95

4:00 p.m. ET: FDA confirms remdesivir puncture use authorization

The U.S. Food and Drug administration reliable President Donald Trump’s progressing remarks that Gilead’s remdesivir antiviral diagnosis perceived puncture use authorisation for a coronavirus illness for hospitalized patients, according to a matter Friday.

3:50 p.m. ET: Trump says FDA has authorized Gilead’s remdesivir for puncture use

President Donald Trump told reporters Friday that Gilead perceived puncture use authorisation for a anti-viral diagnosis to be used for patients with COVID-19, according to reports from mixed outlets.

Gilead’s batch pared waste of some-more than 5% progressing in a event to trade about 4% lower, or during about $80 per share.

2:42 p.m. ET: WTI wanton settles during two-week high

West Texas middle (WTI) wanton oil prices rose for a third true event to settle during a two-week high of $19.78 per barrel. Friday’s benefit noted an allege of 5%, or 94 cents per barrel. The commodity’s weekly benefit was 14.6%.

Friday’s allotment – a initial in May – comes on a heels of a abrasive Apr for crude, with WTI futures during one prove branch disastrous for a initial time in history. The commodity had strew 8% for a month of April, and stays reduce by 68% for a year to date.

11:18 a.m. ET: Tesla shares penetrate after Elon Musk tweets ‘stock cost is too high’

Tesla’s (TSLA) batch extended progressing declines Friday morning, dropping some-more than 7% to next $730 per share as of 11:18 a.m. ET, after a electric car-maker’s Elon Musk wrote in a Twitter post that Tesla’s batch cost was “too high.”

Tesla’s batch was adult scarcely 87% for a year to date by Thursday’s close, distant outperforming a broader market.

The remarks were partial of a array of tweets Musk expelled over a 10-minute duration Friday morning. The billionaire also pronounced that he is “selling roughly all earthy possessions” and will “own no house.” In a Twitter successive Twitter post, he said, “Now give people behind their FREEDOM.”

Earlier this week, Tesla reported first-quarter sales expansion over final year and an astonishing profit. However, a association has been contending with a weekslong proxy cessation of operations during a flagship Fremont, California bureau and New York trickery amid a COVID-19 pandemic, potentially pressuring formula in a stream quarter. During a call Wednesday with analysts and investors, Musk went on an expletive-laden malediction job for amicable enmity measures to be fast rolled back.

10:00 a.m. ET: U.S. prolongation activity sinks deeper into contraction in April: Institute for Supply Management

The Institute for Supply Management’s (ISM) prolongation purchasing managers’ index (PMI) slid to 41.5 in Apr from 49.1 in March. The outcome was somewhat above accord estimates for a dump to 36.0, however, according to Bloomberg data.

Subindices measuring production, new orders and practice any fell during faster paces relations to March. Prints next a neutral turn of 50 prove contraction in activity.

“Comments from a row were strongly disastrous (three disastrous comments for each one certain comment) per a near-term outlook, with view clearly impacted by a coronavirus (COVID-19) pestilence and stability appetite marketplace recession,” ISM pronounced in a statement. “The PMI indicates a turn of manufacturing-sector contraction not seen given Apr 2009, with a strongly disastrous trajectory.”

9:45 a.m. ET: Apr Markit U.S. prolongation PMI sinks to lowest turn given 2009 as outlay drops by a record

IHS Markit’s final U.S. prolongation PMI for Apr sank to 36.1 from 48.5, attack a lowest reading given Mar 2009 and descending for a second uninterrupted month.

Beneath a title index, prolongation outlay slumped to 28.8 in Apr from 46.5 in March, representing a record decline. Readings next a neutral turn of 50 prove contraction in a sector. Meanwhile, new orders fell contra a before month to a lowest turn given Jan 2009.

“April saw a prolongation zone struck tough by a COVID-19 pandemic, with outlay descending to an border leading that seen even during a tallness of a tellurian financial crisis. With orders collapsing during a rate not seen for over a decade, supply bondage disrupted to a record grade and melancholy about a opinion attack a new consult high, rising numbers of firms are culling payroll numbers,” Chris Williamson, arch business economist during IHS Markit, pronounced in a statement.

9:33 a.m. ET: Stocks open reduce after temperate tech quarterly results

Here were a categorical moves in markets, as of 9:33 a.m. ET:

  • SP 500 (^GSPC): -49.96 points (-1.72%) to 2,862.47

  • Dow (^DJI): -380.37 points (-1.56%) to 23,965.35

  • Nasdaq (^IXIC): -171.22 points (-1.93%) to 8,720.13

  • Crude (CL=F): +$1.16 (+6.16%) to $20.00 a barrel

  • Gold (GC=F): -$6.90 (-0.41%) to $1,687.30 per ounce

  • 10-year Treasury (^TNX): -0.7 bps to produce 0.618%

9:00 a.m. ET: Exxon Mobil reports initial quarterly detriment in decades, Chevron cuts collateral expenditures again

Quarterly formula from oil majors Exxon Mobil (XOM) and Chevron (CVX) reflected a early impact of a wretchedness in oil markets during a corporate level.

Exxon Mobil reported a initial quarterly detriment in during slightest 32 years, with waste totaling $610 million for a initial 3 months of a year contra income of $2.4 billion in a same entertain a year ago. However, a association over from other vital oil companies in adhering to its formerly announced skeleton to cut collateral expenditures by $10 billion to $23 billion for a year.

Chevron, on a other hand, cut a collateral expenditures skeleton again following wanton oil prices’ Apr slump. The association cut a capex skeleton buy $2 billion to $14 billion, after creatively formulation capex to come in during $20 billion for a year. These reductions are mostly going to strike Chevron’s shale production, with activity in both a Permian Basin and Canada removing slashed. Refining operations are also going to bear some of that cut. 

While Chevron eked out a first-quarter profit, a formula highlighted some of a direct drop for downstream products that have resulted from a coronavirus pandemic. Jet fuel direct was down 75%, and diesel direct forsaken 25%, a association pronounced in a display Friday.

7:23 a.m. ET Friday: Stock futures fall

Here were a categorical moves in markets forward of a opening bell, as of 7:24 a.m. ET:

  • SP 500 futures (ES=F): down 59.5 points, or 2.05%, to 2,843.00

  • Dow futures (YM=F): down 461.00 points, or 1.90%, to 23,769.00

  • Nasdaq futures (NQ=F): down 229.00 points, or 2.55%, to 8,759.5

  • Crude (CL=F): -$0.03 (-0.16%) to $18.81 a barrel

  • Gold (GC=F): -$7.00 (-0.41%) to $1,687.20 per ounce

  • 10-year Treasury (^TNX): -1.3 bps to produce 0.612%

6:02 p.m. ET Thursday: Stock futures open lower

Stock futures forked to a reduce open on Friday, as investors braced for some-more benefit and information that are all though certain to uncover how badly a coronavirus has mutilated tellurian growth.

Here were a categorical moves during a start of a overnight event for U.S. equity futures, as of 6:02 p.m. ET:

  • SP 500 futures (ES=F): down 38 points, or 1.31%, to 2,864.5

  • Dow futures (YM=F): down 260 points, or 1.07%, to 23,970.00

  • Nasdaq futures (NQ=F): down 157.25 points, or 1.75%, to 8,831.25

Wall Street and New York Stock Exchange in Downtown Manhattan, New York City, USAWall Street and New York Stock Exchange in Downtown Manhattan, New York City, USA

Follow Yahoo Finance on TwitterFacebookInstagramFlipboardLinkedIn, and reddit.

Find live batch marketplace quotes and a latest business and financial news

For tutorials and information on investing and trade stocks, check out Cashay

Free WhoisGuard with Every Domain Purchase at Namecheap